Are Myths and Preconceptions Preventing us from Applying Ionic Liquid Forms of Antiviral Medicines to the Current Health Crisis?
At the moment, there are no U.S. Food and Drug Administration (U.S. FDA)-approved drugs for the treatment of COVID-19, although several antiviral drugs are available for repurposing. Many of these drugs suffer from polymorphic transformations with changes in the drug’s safety and efficacy; many are...
Main Authors: | Julia L. Shamshina, Robin D. Rogers |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6002 |
Similar Items
-
Drug‑Drug and Drug‑Nutraceutical Cocrystal/Salt as Alternative Medicine for Combination Therapy: A Crystal Engineering Approach
by: Ranjit Thakuria, et al.
Published: (2018-02-01) -
Pharmaceutical Cocrystals—A Review
by: Sheetal S. Buddhadev, et al.
Published: (2020-03-01) -
Antimicrobial Activities of Highly Bioavailable Organic Salts and Ionic Liquids from Fluoroquinolones
by: Miguel M. Santos, et al.
Published: (2020-07-01) -
Alendronic Acid as Ionic Liquid: New Perspective on Osteosarcoma
by: Sónia Teixeira, et al.
Published: (2020-03-01) -
Analysis Of Intermolecular Interactions In Pharmaceutical Salts And Cocrystals
by: Dasgupta, Archi
Published: (2013)